Novocure appoints President Frank Leonard as CEO; Ashley Cordova resigns

NovoCure Ltd

Ashley Cordova resigned as CEO and director effective Nov 30, 2025; no disagreement related to operations.
Frank Leonard, previously President, becomes CEO effective Dec 1, 2025; he joined Novocure in 2010.
Cordova enters garden leave through May 31, 2026, with salary, benefits, bonus, and CHF 375,000 cash payment.
Leonard led global business operations since Jan 2024 and prior innovation/product development.
Executive Chairman William Doyle cites Leonard as ideal for upcoming transformative milestones.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.